Narelle S. Cox , 1 , Christine F. McDonald 2 , Jennifer A. Alison 3 , Ajay Mahal 4 , Richard Wootton 5 , Catherine J. Hill 6 , Janet Bondarenko 7 , Heather Macdonald 8 , Paul O’Halloran 9 , Paolo Zanaboni 5 , Ken Clarke 10 , Deidre Rennick 8 , Kaye Borgelt 11 , Angela T. Burge 12 , Aroub Lahham 1 , Bruna Wageck 13 , Hayley Crute 8 , Pawel Czupryn 11 , Amanda Nichols 14 , Anne E. Holland 12
15 May 2018
Pulmonary rehabilitation is an effective therapeutic intervention for people with chronic respiratory disease. However, fewer than 5% of eligible individuals receive pulmonary rehabilitation on an annual basis, largely due to limited availability of services and difficulties associated with travel and transport. The Rehabilitation Exercise At Home (REAcH) study is an assessor-blinded, multi-centre, randomised controlled equivalence trial designed to compare the efficacy of home-based telerehabilitation and traditional centre-based pulmonary rehabilitation in people with chronic respiratory disease.
Participants will undertake an 8-week group-based pulmonary rehabilitation program of twice-weekly supervised exercise training, either in-person at a centre-based pulmonary rehabilitation program or remotely from their home via the Internet. Supervised exercise training sessions will include 30 min of aerobic exercise (cycle and/or walking training). Individualised education and self-management training will be delivered. All participants will be prescribed a home exercise program of walking and strengthening activities.
Outcomes will be assessed by a blinded assessor at baseline, after completion of the intervention, and 12-months post intervention. The primary outcome is change in dyspnea score as measured by the Chronic Respiratory Questionnaire – dyspnea domain (CRQ-D). Secondary outcomes will evaluate the efficacy of telerehabilitation on 6-min walk distance, endurance cycle time during a constant work rate test, physical activity and quality of life. Adherence to pulmonary rehabilitation between the two models will be compared. A full economic analysis from a societal perspective will be undertaken to determine the cost-effectiveness of telerehabilitation compared to centre-based pulmonary rehabilitation.
Alternative models of pulmonary rehabilitation are required to improve both equity of access and patient-related outcomes. This trial will establish whether telerehabilitation can achieve equivalent improvement in outcomes compared to traditional centre-based pulmonary rehabilitation. If efficacious and cost-effective, the proposed telerehabilitation model is designed to be rapidly deployed into clinical practice.
Clinical trial registered with the Australian and New Zealand Clinical Trials Register at ( ACTRN12616000360415). Registered 21 March 2016.